You searched for prescription-drugs | Page 3 of 168

Medicare Part D in 2024: A First Look at Prescription Drug Plan Availability, Premiums, and Cost Sharing

Nov 8, 2023

Issue Brief

Medicare Part D prescription drug coverage is available for people with Medicare who enroll in private plans, either a stand-alone prescription drug plan (PDP) for people in traditional Medicare, or a Medicare Advantage plan that covers all Medicare benefits, including prescription drugs (MA-PD). This issue brief provides an overview of Part D plan availability and premiums in 2024 and key trends over time.

How Will the Prescription Drug Provisions in the Inflation Reduction Act Affect Medicare Beneficiaries?

Jan 24, 2023

Issue Brief

The brief provides a quick explainer of the prescription drug provisions in the Inflation Reduction Act signed into law on August 16, 2022 and presents new estimates on how many Medicare beneficiaries could be helped by those provisions.

10 Prescription Drugs Accounted for $48 Billion in Medicare Part D Spending in 2021, or More Than One-Fifth of Part D Spending That Year

Jul 12, 2023

News Release

A new KFF analysis finds that the 10 top-selling prescription drugs under Medicare Part D comprised less than 1 percent of all covered drugs in 2021, but accounted for 22 percent, or $48 billion, of gross Medicare Part D drug spending that year.

How Would the Prescription Drug Provisions in the Senate Reconciliation Proposal Affect Medicare Beneficiaries?

Jul 27, 2022

Issue Brief

The brief provides a quick explainer of the prescription drug provisions in legislative text released by the Senate Finance Committee to be included in a forthcoming reconciliation bill and presents new estimates on how many Medicare beneficiaries could be helped by those provisions.

Executive Actions to Address Prescription Drug Affordability in the U.S.

Event Date: May 23, 2022

Event

On May 23, 2022, a panel of experts joined series moderator Larry Levitt in a 45-minute discussion exploring the drivers of rising drug prices and potential administrative actions to address them.

How Do Prescription Drug Costs in the United States Compare to Other Countries?

Feb 8, 2022

Feature

This chart collection examines what we know about prescription drug spending and use in the U.S. and comparably large and wealthy countries, using data from the Organization for Economic Cooperation and Development (OECD).

Medicaid Outpatient Prescription Drug Trends During the COVID-19 Pandemic

Dec 14, 2021

Issue Brief

This data note describes Medicaid prescription drug utilization and spending trends in calendar year 2020 compared to previous years to explore how the pandemic impacted Medicaid prescription drug utilization and spending.

Explaining the Prescription Drug Provisions in the Build Back Better Act

Nov 23, 2021

Issue Brief

The Build Back Better Act includes several provisions that would lower prescription drug costs for people with Medicare and private insurance and reduce drug spending by the federal government and private payers. This brief summarizes these provisions and discusses the expected effects on people, program spending, and drug prices and innovation.

Summary of Costs and Impact of the Prescription Drug Provisions in the Build Back Better Act

Nov 23, 2021

News Release

As the House-passed Build Back Better Act moves to the Senate, a new explainer from KFF summarizes the key prescription drug provisions within the broader budget reconciliation bill. These provisions would lower prescription drug costs paid by people with Medicare and private insurance and curb drug spending by the federal government and private payers.

Dec. 8 Event: Unpacking the Prescription Drug Provisions of the Build Back Better Act

Event Date: Dec 8, 2021

Event

As the Build Back Better Act shifts from the House to the Senate, there’s considerable interest in provisions that would lower the cost of prescription drugs.

Topics

Policy Research

Polling

Health News

Data & Features

For Media

About

Search

Filter